Literature DB >> 2073095

Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.

K V Singh1, R R Reves, L K Pickering, B E Murray.   

Abstract

A high prevalence of fecal colonization with trimethoprim-resistant Escherichia coli was found in diapered children attending day-care centers in Houston, Tex. In the present study, 100 isolates of E. coli resistant to multiple antibiotics, including trimethoprim (100%), sulfisoxazole (100%), streptomycin (94%), and ampicillin (87%), were obtained over a 5-month period from stool samples of diapered children attending four day-care centers and tested for their susceptibilities to amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin. The MICs for 50 and 90% of strains tested were 16 and 32 micrograms/ml, respectively, for amoxicillin-clavulanic acid, 4 and 16 micrograms/ml, respectively, for cefuroxime, 4 and 64 micrograms/ml, respectively, for cephalexin, and 32 and greater than 64 micrograms/ml, respectively, for cephalothin. Although all three oral beta-lactams tested were generally active at concentrations likely to be achieved in urine, cefuroxime and cephalexin were more potent and are thus more likely to be inhibitory at the concentrations needed for systemic infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073095      PMCID: PMC171996          DOI: 10.1128/AAC.34.11.2047

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

2.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

3.  Diarrhea in day care centers.

Authors:  L K Pickering; W E Woodward
Journal:  Pediatr Infect Dis       Date:  1982 Jan-Feb

4.  Cefuroxime, a new cephalosporin antibiotic: activity in vitro.

Authors:  C H O'Callaghan; R B Sykes; A Griffiths; J E Thornton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas.

Authors:  R R Reves; M Fong; L K Pickering; A Bartlett; M Alvarez; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

6.  Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.

Authors:  W Cullmann; W Dick; M Stieglitz; W Opferkuch
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

7.  Intrafamilial spreading of Escherichia coli resistant to trimethoprim.

Authors:  J Rydberg; A Cederberg
Journal:  Scand J Infect Dis       Date:  1986

8.  In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.

Authors:  P C Fuchs; R N Jones; A L Barry; C Thornsberry; L W Ayers; T L Gavan; E H Gerlach
Journal:  Diagn Microbiol Infect Dis       Date:  1986-07       Impact factor: 2.803

9.  Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.

Authors:  R R Reves; B E Murray; L K Pickering; D Prado; M Maddock; A V Bartlett
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

10.  In vitro of cefotaxime against cephalothin-resistant clinical isolates.

Authors:  H W Van Landuyt; M Pyckavet
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

View more
  3 in total

1.  The prevalence of antimicrobial resistance in human faecal flora in South Africa.

Authors:  P M Shanahan; B A Wylie; P V Adrian; H J Koornhof; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

Review 2.  Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

Review 3.  Faecal carriage of antibiotic resistant Escherichia coli in asymptomatic children and associations with primary care antibiotic prescribing: a systematic review and meta-analysis.

Authors:  Ashley Bryce; Céire Costelloe; Claire Hawcroft; Mandy Wootton; Alastair D Hay
Journal:  BMC Infect Dis       Date:  2016-07-25       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.